Clinical evidence for ibogaine in addiction treatment—primarily from observational studies outside the U.S.—suggests improvements in withdrawal, cravings, and mental health. However, the data is limited by lack of controlled trials, inconsistent protocols, and reliance on self-reported outcomes, raising important questions about reliability, safety, and long-term effectiveness.